Gaithersburg biotech firm wins $1.6B to develop coronavirus vaccine

The Trump administration has awarded a contract worth $1.6 billion to a Maryland biotechnology company to develop a coronavirus vaccine, the largest bet yet by the federal government on an individual vaccine to combat the pandemic. The deal with Novavax, a publicly traded company based in Gaithersburg, will pay for late-stage clinical trials and secure 100 ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.